Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Pharmacology|November 13, 2003
Impact of psychostimulants on vesicular monoamine transporter functionAnnette E Fleckenstein, Glen R Hanson
The AAPS Journal|July 1, 2006
Mechanisms of methamphetamine-induced dopaminergic neurotoxicityEvan L Riddle, Annette E Fleckenstein, Glen R Hanson
Synapse (New York, N.Y.)|August 10, 2006
Kinetic analysis of developmental changes in vesicular monoamine transporter-2 functionTrent J Volz, Glen R Hanson, Annette E Fleckenstein
Journal of Neuroscience Methods|February 17, 2006
Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetryTrent J Volz, Glen R Hanson, Annette E Fleckenstein
Journal of Neurochemistry|July 19, 2012
Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalizationChristopher L German, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology|July 30, 2008
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implicationsAnnette E Fleckenstein, Trent J Volz, Glen R Hanson
Journal of Neurochemistry|January 26, 2007
The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficitsTrent J Volz, Glen R Hanson, Annette E Fleckenstein
European Journal of Pharmacology|July 10, 2007
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2Evan L Riddle, Glen R Hanson, Annette E Fleckenstein
Life Sciences|August 6, 2013
Bath salts and synthetic cathinones: an emerging designer drug phenomenonChristopher L German, Annette E Fleckenstein, Glen R Hanson
The AAPS Journal|April 6, 2006
Role of monoamine transporters in mediating psychostimulant effectsEvan L Riddle, Annette E Fleckenstein, Glen R Hanson
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|November 13, 2003
Impact of psychostimulants on vesicular monoamine transporter functionAnnette E Fleckenstein, Glen R Hanson
The AAPS Journal|July 1, 2006
Mechanisms of methamphetamine-induced dopaminergic neurotoxicityEvan L Riddle, Annette E Fleckenstein, Glen R Hanson
Synapse (New York, N.Y.)|August 10, 2006
Kinetic analysis of developmental changes in vesicular monoamine transporter-2 functionTrent J Volz, Glen R Hanson, Annette E Fleckenstein
Journal of Neuroscience Methods|February 17, 2006
Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetryTrent J Volz, Glen R Hanson, Annette E Fleckenstein
Journal of Neurochemistry|July 19, 2012
Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalizationChristopher L German, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology|July 30, 2008
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implicationsAnnette E Fleckenstein, Trent J Volz, Glen R Hanson
Journal of Neurochemistry|January 26, 2007
The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficitsTrent J Volz, Glen R Hanson, Annette E Fleckenstein
European Journal of Pharmacology|July 10, 2007
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2Evan L Riddle, Glen R Hanson, Annette E Fleckenstein
Life Sciences|August 6, 2013
Bath salts and synthetic cathinones: an emerging designer drug phenomenonChristopher L German, Annette E Fleckenstein, Glen R Hanson
The AAPS Journal|April 6, 2006
Role of monoamine transporters in mediating psychostimulant effectsEvan L Riddle, Annette E Fleckenstein, Glen R Hanson
Pageof 8